Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

This publication has 35 references indexed in Scilit:

• SPONTANEOUS PRODUCTION OF FIBRONECTIN BY ALVEOLAR MACROPHAGES IN PATIENTS WITH SCLERODERMA
  Arthritis & Rheumatism, 1989
• A Clinical, Radiographic, and Physiologic Scoring System for the Longitudinal Assessment of Patients with Idiopathic Pulmonary Fibrosis^1–3
  American Review of Respiratory Disease, 1986
• Evidence for Chronic Inflammation as a Component of the Interstitial Lung Disease Associated with Progressive Systemic Sclerosis
  American Review of Respiratory Disease, 1985
• Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis
  The American Journal of Medicine, 1984
• Lung Involvement in Scleroderma
  Chest, 1984
• Safety of Fiberoptic Bronchoalveolar Lavage in Evaluation of Interstitial Lung Disease
  Chest, 1981
• Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.
  Thorax, 1980
• Preliminary criteria for the classification of systemic sclerosis (scleroderma)
  Arthritis & Rheumatism, 1980
• Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.
  Journal of Clinical Investigation, 1977
• Survival with Systemic Sclerosis (Scleroderma)
  Annals of Internal Medicine, 1971